Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sodium Oxybate in Essential Tremor
NCT00598078Phase 2Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Dec 2007
- Primary completion
- Aug 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium oxybate in essential tremor (ET) (3 arms), sponsored by Jazz Pharmaceuticals plc. Primary endpoint: Modified Fahn-Tolosa-Marin Essential Tremor Rating Scale at 1 hour. Started Dec 2007; status: completed.
02
Drugs
sodium oxybate
03
Conditions
essential tremor (ET)
Beyond the preview
Go deeper on NCT00598078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00598078.